These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 31357959)

  • 1. Have we achieved adequate recommendations for target volume definitions in anal cancer? A PET imaging based patterns of failure analysis in the context of established contouring guidelines.
    Dapper H; Schiller K; Münch S; Peeken JC; Borm K; Weber W; Combs SE
    BMC Cancer; 2019 Jul; 19(1):742. PubMed ID: 31357959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of pathologic lymph nodes in anal cancer: a PET-CT-based analysis with implications for radiotherapy treatment volumes.
    Frennered A; Scherman J; Buchwald P; Johnsson A; Sartor H; Zackrisson S; Trägårdh E; Nilsson MP
    BMC Cancer; 2021 Apr; 21(1):447. PubMed ID: 33888074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of inguinal lymph node metastases in anal canal cancer and recommendations for elective clinical target volume (CTV) delineation.
    Garda AE; Navin PJ; Merrell KW; Martenson JA; Neben Wittich MA; Haddock MG; Sio TT; Rule WG; Ashman JB; Sheedy SP; Hallemeier CL
    Radiother Oncol; 2020 Aug; 149():128-133. PubMed ID: 32417349
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Australasian Gastrointestinal Trials Group (AGITG) contouring atlas and planning guidelines for intensity-modulated radiotherapy in anal cancer.
    Ng M; Leong T; Chander S; Chu J; Kneebone A; Carroll S; Wiltshire K; Ngan S; Kachnic L
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1455-62. PubMed ID: 22401917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Castellano I; Cassoni P; Ricardi U; Munoz F; Racca P; Contu V; Beltramo G; Morino M; Mussa A
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):73-8. PubMed ID: 19632066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDG/PET-CT-Based Lymph Node Atlas in Breast Cancer Patients.
    Borm KJ; Voppichler J; Düsberg M; Oechsner M; Vag T; Weber W; Combs SE; Duma MN
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):574-582. PubMed ID: 30118822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSMA-PET/CT-based Lymph Node Atlas for Prostate Cancer Patients Recurring After Primary Treatment: Clinical Implications for Salvage Radiation Therapy.
    Schiller K; Stöhrer L; Düsberg M; Borm K; Devecka M; Vogel MME; Tauber R; Heck MM; Rauscher I; Eiber M; Gschwend JE; Duma MN; Combs SE
    Eur Urol Oncol; 2021 Feb; 4(1):73-83. PubMed ID: 32451312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of positron emission tomography-computed tomography in the management of anal cancer.
    Mistrangelo M; Pelosi E; Bellò M; Ricardi U; Milanesi E; Cassoni P; Baccega M; Filippini C; Racca P; Lesca A; Munoz FH; Fora G; Skanjeti A; Cravero F; Morino M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):66-72. PubMed ID: 22592047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dosimetric comparison of organs at risk using different contouring guidelines for definition of the clinical target volume in anal cancer.
    Dapper H; Oechsner M; Münch S; Diehl C; Peeken JC; Borm K; Combs SE
    Strahlenther Onkol; 2020 Apr; 196(4):368-375. PubMed ID: 32016496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An atlas to aid delineation of para-aortic lymph node region in cervical cancer: Design and validation of contouring guidelines.
    Keenan LG; Rock K; Azmi A; Salib O; Gillham C; McArdle O
    Radiother Oncol; 2018 Jun; 127(3):417-422. PubMed ID: 29523410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elective clinical target volumes for conformal therapy in anorectal cancer: a radiation therapy oncology group consensus panel contouring atlas.
    Myerson RJ; Garofalo MC; El Naqa I; Abrams RA; Apte A; Bosch WR; Das P; Gunderson LL; Hong TS; Kim JJ; Willett CG; Kachnic LA
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):824-30. PubMed ID: 19117696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of sentinel lymph-node biopsy and FDG-PET in staging and radiation treatment of anal cancer patients.
    Slim N; Passoni P; Incerti E; Tummineri R; Gumina C; Cattaneo GM; De Nardi P; Canevari C; Fiorino C; Ronzoni M; Tamburini AM; Burgio V; Gianolli L; Di Muzio N
    Sci Rep; 2020 Sep; 10(1):14613. PubMed ID: 32884036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of
    Schiller K; Devecka M; Maurer T; Eiber M; Gschwend J; Schwaiger M; Combs SE; Habl G
    Radiat Oncol; 2018 Mar; 13(1):36. PubMed ID: 29490670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consensus Guidelines and Contouring Atlas for Pelvic Node Delineation in Prostate and Pelvic Node Intensity Modulated Radiation Therapy.
    Harris VA; Staffurth J; Naismith O; Esmail A; Gulliford S; Khoo V; Lewis R; Littler J; McNair H; Sadoyze A; Scrase C; Sohaib A; Syndikus I; Zarkar A; Hall E; Dearnaley D;
    Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):874-83. PubMed ID: 26104940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography-based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline.
    Vogel MME; Düsberg M; Stöhrer L; Dewes S; Sage EK; Borm KJ; Gschwend JE; Eiber M; Combs SE; Schiller K
    Eur Urol Oncol; 2022 Dec; 5(6):668-676. PubMed ID: 36280446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer.
    Bannas P; Weber C; Adam G; Frenzel T; Derlin T; Mester J; Klutmann S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):445-51. PubMed ID: 20832181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positron emission tomography/computed tomography in the staging and treatment of anal cancer.
    Sveistrup J; Loft A; Berthelsen AK; Henriksen BM; Nielsen MB; Engelholm SA
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):134-41. PubMed ID: 22000745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-institutional Development and Validation of Contouring Guidelines for Para-aortic Elective Nodal Irradiation in Prostate Cancer Based on Patterns of Involvement on Targeted Molecular Imaging Positron Emission Tomography/Computed Tomography.
    Saripalli AL; Lee B; Adams W; Bhandare N; Venkatesulu BP; Yoo RK; Price J; Harmon GA; Block AM; Friedman N; Harkenrider MM; Major EJ; Small W; Wagner RH; Welsh JS; Solanki AA
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):630-640. PubMed ID: 37201758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic tumour volume of anal carcinoma on (18)FDG PET/CT before combined radiochemotherapy is the only independant determinant of recurrence free survival.
    Mohammadkhani Shali S; Schmitt V; Behrendt FF; Winz OH; Heinzel A; Mottaghy FM; Eble MJ; Verburg FA
    Eur J Radiol; 2016 Aug; 85(8):1390-4. PubMed ID: 27423677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.